Literature DB >> 26721736

The y6 receptor suppresses bone resorption and stimulates bone formation in mice via a suprachiasmatic nucleus relay.

Ee-Cheng Khor1, Ernie Yulyaningsih2, Frank Driessler1, Natasha Kovaĉić1, Natalie K Y Wee1, Rishikesh N Kulkarni1, Nicola J Lee3, Ronaldo F Enriquez1, Jiake Xu4, Lei Zhang2, Herbert Herzog3, Paul A Baldock5.   

Abstract

The neuropeptide Y system is known to play an important role in the regulation of bone homeostasis and while the functions of its major receptors, Y1R and Y2R, in this process have become clearer, the contributions of other Y-receptors, like the y6 receptor (y6R), are unknown. Y6R expression is restricted to the suprachiasmatic nucleus (SCN) of the hypothalamus, an area known to regulate circadian rhythms, and the testis. Here we show that lack of y6R signalling, results in significant reduction in bone mass, but no changes in bone length. Male and female y6R knockout (KO) mice display reduced cortical and cancellous bone volume in axial and appendicular bones. Mechanistically, the reduction in cancellous bone is the result of an uncoupling of bone remodelling, leading to an increase in osteoclast surface and number, and a reduction in osteoblast number, osteoid surface, mineralizing surface and bone formation rate. y6R KO mice displayed increased numbers of osteoclast precursors and produced greater numbers of osteoclasts in RANKL-treated cultures. They also produced fewer CFU-ALP osteoblast precursors in the marrow and showed reduced mineralization in primary osteoblastic cultures, as well as reduced expression for the osteoblast lineage marker, alkaline phosphatase, in bone isolates. The almost exclusive location of y6Rs in the hypothalamus suggests a critical role of central neuronal pathways controlling this uncoupling of bone remodelling which is in line with known actions or other Y-receptors in the brain. In conclusion, y6R signalling is required for maintenance of bone mass, with loss of y6R uncoupling bone remodelling and resulting in a negative bone balance. This study expands the scope of hypothalamic regulation of bone, highlighting the importance for neural/endocrine coordination and their marked effect upon skeletal homeostasis.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Bone; Hypothalamus; Neuropeptide Y; Osteoblast; Osteoclast; y6 receptor

Mesh:

Substances:

Year:  2015        PMID: 26721736     DOI: 10.1016/j.bone.2015.12.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Skeletal phenotype of the neuropeptide Y knockout mouse.

Authors:  Natalie K Y Wee; Benjamin P Sinder; Sanja Novak; Xi Wang; Chris Stoddard; Brya G Matthews; Ivo Kalajzic
Journal:  Neuropeptides       Date:  2018-11-30       Impact factor: 3.286

Review 2.  PET Imaging of the Neuropeptide Y System: A Systematic Review.

Authors:  Inês C F Fonseca; Miguel Castelo-Branco; Cláudia Cavadas; Antero J Abrunhosa
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

Authors:  Albert Shieh; Weijuan Han; Shinya Ishii; Gail A Greendale; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

4.  [Neuropeptide Y Y1 receptor antagonist PD160170 promotes osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro and femoral defect repair in rats].

Authors:  Song Liu; Jian-Qun Wu; Ji-Jie Hu; Le Wang; Zhao Wang; Huan Meng; Ling-Jian Zhuo; Jian-Xiong Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

Review 5.  Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy.

Authors:  Song Peng; You-Li Zhou; Zhi-Yuan Song; Shu Lin
Journal:  Stem Cells Int       Date:  2017-10-03       Impact factor: 5.443

Review 6.  Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

Review 7.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

Review 8.  The role of GPCRs in bone diseases and dysfunctions.

Authors:  Jian Luo; Peng Sun; Stefan Siwko; Mingyao Liu; Jianru Xiao
Journal:  Bone Res       Date:  2019-07-08       Impact factor: 13.567

9.  Neuromodulation of bone: Role of different peptides and their interactions (Review).

Authors:  Xiaoyu Wang; Jia Xu; Qinglin Kang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

Review 10.  Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.